SEC Comment Letter 0000000000-24-007793 to Cardiff Lexington Corp (CDIX)
Cardiff Lexington Corp
Date: July 10, 2024 · CIK: 0000811222 · Accession: 0000000000-24-007793
AI Filing Summary & Sentiment
File numbers found in text: 000-49709
Show Raw Text
July 10, 2024
Matthew Shafer
Chief Financial Officer
Cardiff Lexington Corp
3753 Howard Hughes Parkway, Suite 200
Las Vegas, NV 89169
Re:Cardiff Lexington Corp
Form 10-K for Fiscal Year Ended December 31, 2023
Filed March 27, 2024
File No. 000-49709
Dear Matthew Shafer:
We have limited our review of your filing to the financial statements and related
disclosures and have the following comment.
Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
After reviewing your response to this letter, we may have additional comments.
Form 10-K for Fiscal Year Ended December 31, 2023
1. Summary of Significant Accounting Policies
Accounts Receivable, page F-9
We note that as of December 31, 2023, the accounts receivable-net balance is
$13,305,254 compared to total revenue of $11,853,266 for fiscal year 2023. Please
address the following:
•Comprehensively explain why the accounts receivable-net year-end balance increased
$6,701,334, or 101.5%, compared to the revenue increase of $1,160,070, or 10.8%.
Also, with reference to the $2,661,966 revenue recognized for the first quarter of
fiscal year 2024, explain why the year-end account receivable-net balance increased
by $1,344,676 to $14,649,930.
•Address how you concluded that the accounts receivable-net balance is collectible as
of December 31, 2023 and March 31, 2024. As part of your response, tell us which
method you used to measure expected credit losses for your accounts receivable-net
and how much of the balance has been collected to date.1.
July 10, 2024
Page 2
•Provide us with an aging of your accounts receivables as of December 31, 2023, and
March 31, 2024.
•Confirm that you will provide expanded MD&A disclosures to provide a
comprehensive discussion of the reasons underlying changes in your accounts
receivable-net balances for each period presented as well as a comprehensive analysis
of the collectability of these balances. This discussion should address any material
aging of your account balances. Refer to Item 303(b)(1) of Regulation S-K,
Instruction 4 of Item 303(b) of Regulation S-K and Section 501.13. of the Financial
Reporting Codification (i.e., Release 33-8350, Section IV.).
•Tell us how you concluded that it was probable you would collect substantially all the
consideration you were entitled to under your customer contracts. Refer to ASC 606-
10-25-1.e. and ASC 606-10-25-5 through 25-7.
•Tell us the significant payment terms and confirm that you will provide this
disclosure in accordance with ASC 606-10-50-12.b.
•Provide us with a rollforward of the allowance for credit losses for each period
prepared in accordance with ASC 326-20-50-13 and confirm that you will provide
this disclosure along with the disclosures required by ASC 326-20-50-11 and ASC
326-20-50-17.
In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
Please contact Tracey Houser at 202-551-3736 or Jeanne Baker at 202-551-3691 with any
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services